Articles related to OBESITY/WEIGHT MANAGEMENT

Stopping GLP-1 drugs can lead to significant weight regain and increased appetite. Understanding the biological mechanisms and preparing patients for these changes is crucial for effective management.

Plain black coffee has negligible calories and may aid weight maintenance, while coffee additives and caffeine’s impact on sleep and appetite can contribute to weight gain.

Patients on GLP-1 medications may experience notable changes in breast morphology, such as decreased volume and increased sagging. Medical experts recommend supportive measures and a stable weight before considering surgical interventions.

Ozempic, commonly used off-label for weight management, can cause significant facial side effects, termed “Ozempic face,” marked by increased wrinkling and loss of skin elasticity.

Brazzein, now FDA-approved, emerges as a zero-calorie sweetener potentially safe for diabetic and obese populations, requiring further study to validate its health impacts.

Recent studies suggest that GLP-1 receptor agonists, while primarily used for weight loss, may also impact mental health and behavior, potentially due to their effects on the brain’s reward systems.